1. AB0084 Novel regulation of TNF-α-induced-IL-18 bioactivity in rheumatoid arthritis synovial fibroblasts by reducing caspase-1 via JAK2 inhibition. (23rd January 2014) Authors: Marotte, H.; Fedorova, T.; Pinney, A.J.; Lewis, B.; Koch, A.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study. (9th June 2015) Authors: Genovese, M.C.; Kremer, J.; Zamani, O.; Ludivico, C.; Krogulec, M.; Xie, L.; Beattie, S.; Koch, A.E.; Cardillo, T.; Rooney, T.; Macias, W.; Schlichting, D.; Smolen, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗